SIMPONI ARIA® (Golimumab) is an immunosuppressive drug that reduces the body’s inflammation to treat various autoimmune diseases.
SIMPONI ARIA® is manufactured by Janssen Biotech.
Administration and Dosage:
Administration of SIMPONI ARIA follows an induction regimen of intravenous infusions at week 0 and 4 followed by a maintenance infusion every 8 weeks.
Common Side Effects:
The more common side effects of SIMPONI ARIA® include serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
SIMPONI ARIA® is indicated to treat:
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis